Zhejiang Semir Garment Balance Sheet Health
Financial Health criteria checks 6/6
Zhejiang Semir Garment has a total shareholder equity of CN¥11.4B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥18.1B and CN¥6.6B respectively. Zhejiang Semir Garment's EBIT is CN¥1.3B making its interest coverage ratio -6.1. It has cash and short-term investments of CN¥6.0B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -6.1x |
| Cash | CN¥5.99b |
| Equity | CN¥11.44b |
| Total liabilities | CN¥6.65b |
| Total assets | CN¥18.09b |
Recent financial health updates
No updates
Recent updates
Zhejiang Semir Garment Co., Ltd.'s (SZSE:002563) Intrinsic Value Is Potentially 33% Above Its Share Price
Nov 20
Zhejiang Semir Garment Co., Ltd.'s (SZSE:002563) Price Is Right But Growth Is Lacking After Shares Rocket 41%
Oct 03Zhejiang Semir Garment (SZSE:002563) Could Be At Risk Of Shrinking As A Company
Sep 17Little Excitement Around Zhejiang Semir Garment Co., Ltd.'s (SZSE:002563) Earnings
Aug 19Are Investors Undervaluing Zhejiang Semir Garment Co., Ltd. (SZSE:002563) By 33%?
Jul 02Be Wary Of Zhejiang Semir Garment (SZSE:002563) And Its Returns On Capital
Jun 13Zhejiang Semir Garment's (SZSE:002563) Solid Earnings Are Supported By Other Strong Factors
Apr 08Benign Growth For Zhejiang Semir Garment Co., Ltd. (SZSE:002563) Underpins Its Share Price
Mar 27Financial Position Analysis
Short Term Liabilities: 002563's short term assets (CN¥13.0B) exceed its short term liabilities (CN¥6.4B).
Long Term Liabilities: 002563's short term assets (CN¥13.0B) exceed its long term liabilities (CN¥276.7M).
Debt to Equity History and Analysis
Debt Level: 002563 is debt free.
Reducing Debt: 002563 has no debt compared to 5 years ago when its debt to equity ratio was 2.6%.
Debt Coverage: 002563 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 002563 has no debt, therefore coverage of interest payments is not a concern.